APL was acquired by KBI Biopharma, a leading global CDMO, in June 2017. Since the acquisition, APL has continued to provide the high-quality analytical services it has offered since its founding in 1998. We look forward to expanding current client relationships, and building new ones, as part of KBI Biopharma.
Please contact us below to learn more about how we, as part of KBI, can partner with you to support your analytical needs.
APL specializes in biophysical analysis of protein conformation, stability, and aggregation. We were the first contract lab in the US to offer analytical ultracentrifugation (AUC), and our principal scientists pioneered the application of biophysical techniques such as AUC, SEC-MALS, and circular dichroism (CD) in the biotechnology industry.
Alliance Protein Laboratories can provide research-scale protein purification services to generate microgram to gram quantities of proteins purified from either recombinant or natural sources. Our scientists have experience purifying and refolding scores of recombinant proteins from a variety of expression systems.
We do more than just proteins...
Our biophysical characterization techniques have applications to small peptides, nucleic acids (e.g. anti-sense therapeutics, aptamers, ribozymes), small molecule drugs, carbohydrates, vaccines, viruses, drug-polymer conjugates, and more.
APL offers contract research services in the areas of protein and peptide biophysical characterization, protein aggregation, protein purification, and protein stabilization.
If you are looking for analytical ultracentrifugation (AUC), circular dichroism, light scattering, DSC, fluorescence, or native gel analysis of your biotech product, or help with your protein aggregation problems, you have found the right place!
We have now done such analysis on literally hundreds of products, giving our scientists unparalleled experience.